Direct Oral Anticoagulants Versus Vitamin K Antagonists After Mitral Valve Transcatheter Edge‐to‐Edge Repair in Patients With Atrial Fibrillation: A Single‐Center Observational Study
Our findings suggest that direct oral anticoagulants may offer comparable efficacy and safety to VKAs in preventing thromboembolic events following M-TEER in patients with atrial fibrillation. Further randomized trials are needed to confirm these results and establish optimal anticoagulation strategies in this patient population.
Authors
- Max M. Meertens (ORCID: https://orcid.org/0000-0002-7746-8723)
- A Sommer
- Daniel Steven (ORCID: https://orcid.org/0000-0001-6839-5895)
- Tobias Schmidt (ORCID: https://orcid.org/0000-0001-7381-3836)
- Christian Frerker (ORCID: https://orcid.org/0000-0003-0226-0888)
- Christopher Hohmann (ORCID: https://orcid.org/0000-0003-2821-4134)
- Roman Pfister (ORCID: https://orcid.org/0000-0002-4358-5008)
- Jonas Wörmann (ORCID: https://orcid.org/0000-0002-2213-8946)
- Sebastian Dittrich
- Jakob Lüker (ORCID: https://orcid.org/0000-0003-4667-2200)
- Stephan Baldus (ORCID: https://orcid.org/0000-0001-8259-1737)
- Richard J. Nies (ORCID: https://orcid.org/0000-0002-1336-6031)
- Ingo Eitel (ORCID: https://orcid.org/0000-0002-6442-246X)
- Clemens Metze (ORCID: https://orcid.org/0000-0001-8980-4598)
- Jan‐Hendrik Schipper (ORCID: https://orcid.org/0000-0003-0208-3295)
- Jan‐Hendrik van den Bruck (ORCID: https://orcid.org/0000-0003-0468-4887)
- Arian Sultan (ORCID: https://orcid.org/0000-0003-1807-4860)
Institutions
- University of Cologne (DE)
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University Hospital Schleswig-Holstein (DE)
- Asklepios Klinik St. Georg (DE)
- University Hospital Cologne (DE)
- Asklepios (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1161/jaha.124.038834
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Pfizer
- Edwards Lifesciences
- Boston Scientific Corporation
- Daiichi Sankyo Europe